Cargando…

Minimizing dose variation from the interplay effect in stereotactic radiation therapy using volumetric modulated arc therapy for lung cancer

It is important to improve the magnitude of dose variation that is caused by the interplay effect. The aim of this study was to investigate the impact of the number of breaths (NBs) to the dose variation for VMAT‐SBRT to lung cancer. Data on respiratory motion and multileaf collimator (MLC) sequence...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubo, Kazuki, Monzen, Hajime, Tamura, Mikoto, Hirata, Makoto, Ishii, Kentaro, Okada, Wataru, Nakahara, Ryuta, Kishimoto, Shun, Kawamorita, Ryu, Nishimura, Yasumasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849850/
https://www.ncbi.nlm.nih.gov/pubmed/29368420
http://dx.doi.org/10.1002/acm2.12264
_version_ 1783306118547636224
author Kubo, Kazuki
Monzen, Hajime
Tamura, Mikoto
Hirata, Makoto
Ishii, Kentaro
Okada, Wataru
Nakahara, Ryuta
Kishimoto, Shun
Kawamorita, Ryu
Nishimura, Yasumasa
author_facet Kubo, Kazuki
Monzen, Hajime
Tamura, Mikoto
Hirata, Makoto
Ishii, Kentaro
Okada, Wataru
Nakahara, Ryuta
Kishimoto, Shun
Kawamorita, Ryu
Nishimura, Yasumasa
author_sort Kubo, Kazuki
collection PubMed
description It is important to improve the magnitude of dose variation that is caused by the interplay effect. The aim of this study was to investigate the impact of the number of breaths (NBs) to the dose variation for VMAT‐SBRT to lung cancer. Data on respiratory motion and multileaf collimator (MLC) sequence were collected from the cases of 30 patients who underwent radiotherapy with VMAT‐SBRT for lung cancer. The NBs in the total irradiation time with VMAT and the maximum craniocaudal amplitude of the target were calculated. The MLC sequence complexity was evaluated using the modulation complexity score for VMAT (MCSv). Static and dynamic measurements were performed using a cylindrical respiratory motion phantom and a micro ionization chamber. The 1 standard deviation which were obtained from 10 dynamic measurements for each patient were defined as dose variation caused by the interplay effect. The dose distributions were also verified with radiochromic film to detect undesired hot and cold dose spot. Dose measurements were also performed with different NBs in the same plan for 16 patients in 30 patients. The correlations between dose variations and parameters assessed for each treatment plan including NBs, MCSv, the MCSv/amplitude quotient (TMMCSv), and the MCSv/amplitude quotient × NBs product (IVS) were evaluated. Dose variation was decreased with increasing NBs, and NBs of >40 times maintained the dose variation within 3% in 15 cases. The correlation between dose variation and IVS which were considered NBs was shown stronger (R (2) = 0.43, P < 0.05) than TMMCSv (R (2) = 0.32, P < 0.05). The NBs is an important factor to reduce the dose variation. The patient who breathes >40 times during irradiation of two partial arcs VMAT (i.e., NBs = 16 breaths per minute) may be suitable for VMAT‐SBRT for lung cancer.
format Online
Article
Text
id pubmed-5849850
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-58498502018-04-02 Minimizing dose variation from the interplay effect in stereotactic radiation therapy using volumetric modulated arc therapy for lung cancer Kubo, Kazuki Monzen, Hajime Tamura, Mikoto Hirata, Makoto Ishii, Kentaro Okada, Wataru Nakahara, Ryuta Kishimoto, Shun Kawamorita, Ryu Nishimura, Yasumasa J Appl Clin Med Phys Radiation Oncology Physics It is important to improve the magnitude of dose variation that is caused by the interplay effect. The aim of this study was to investigate the impact of the number of breaths (NBs) to the dose variation for VMAT‐SBRT to lung cancer. Data on respiratory motion and multileaf collimator (MLC) sequence were collected from the cases of 30 patients who underwent radiotherapy with VMAT‐SBRT for lung cancer. The NBs in the total irradiation time with VMAT and the maximum craniocaudal amplitude of the target were calculated. The MLC sequence complexity was evaluated using the modulation complexity score for VMAT (MCSv). Static and dynamic measurements were performed using a cylindrical respiratory motion phantom and a micro ionization chamber. The 1 standard deviation which were obtained from 10 dynamic measurements for each patient were defined as dose variation caused by the interplay effect. The dose distributions were also verified with radiochromic film to detect undesired hot and cold dose spot. Dose measurements were also performed with different NBs in the same plan for 16 patients in 30 patients. The correlations between dose variations and parameters assessed for each treatment plan including NBs, MCSv, the MCSv/amplitude quotient (TMMCSv), and the MCSv/amplitude quotient × NBs product (IVS) were evaluated. Dose variation was decreased with increasing NBs, and NBs of >40 times maintained the dose variation within 3% in 15 cases. The correlation between dose variation and IVS which were considered NBs was shown stronger (R (2) = 0.43, P < 0.05) than TMMCSv (R (2) = 0.32, P < 0.05). The NBs is an important factor to reduce the dose variation. The patient who breathes >40 times during irradiation of two partial arcs VMAT (i.e., NBs = 16 breaths per minute) may be suitable for VMAT‐SBRT for lung cancer. John Wiley and Sons Inc. 2018-01-25 /pmc/articles/PMC5849850/ /pubmed/29368420 http://dx.doi.org/10.1002/acm2.12264 Text en © 2018 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Kubo, Kazuki
Monzen, Hajime
Tamura, Mikoto
Hirata, Makoto
Ishii, Kentaro
Okada, Wataru
Nakahara, Ryuta
Kishimoto, Shun
Kawamorita, Ryu
Nishimura, Yasumasa
Minimizing dose variation from the interplay effect in stereotactic radiation therapy using volumetric modulated arc therapy for lung cancer
title Minimizing dose variation from the interplay effect in stereotactic radiation therapy using volumetric modulated arc therapy for lung cancer
title_full Minimizing dose variation from the interplay effect in stereotactic radiation therapy using volumetric modulated arc therapy for lung cancer
title_fullStr Minimizing dose variation from the interplay effect in stereotactic radiation therapy using volumetric modulated arc therapy for lung cancer
title_full_unstemmed Minimizing dose variation from the interplay effect in stereotactic radiation therapy using volumetric modulated arc therapy for lung cancer
title_short Minimizing dose variation from the interplay effect in stereotactic radiation therapy using volumetric modulated arc therapy for lung cancer
title_sort minimizing dose variation from the interplay effect in stereotactic radiation therapy using volumetric modulated arc therapy for lung cancer
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849850/
https://www.ncbi.nlm.nih.gov/pubmed/29368420
http://dx.doi.org/10.1002/acm2.12264
work_keys_str_mv AT kubokazuki minimizingdosevariationfromtheinterplayeffectinstereotacticradiationtherapyusingvolumetricmodulatedarctherapyforlungcancer
AT monzenhajime minimizingdosevariationfromtheinterplayeffectinstereotacticradiationtherapyusingvolumetricmodulatedarctherapyforlungcancer
AT tamuramikoto minimizingdosevariationfromtheinterplayeffectinstereotacticradiationtherapyusingvolumetricmodulatedarctherapyforlungcancer
AT hiratamakoto minimizingdosevariationfromtheinterplayeffectinstereotacticradiationtherapyusingvolumetricmodulatedarctherapyforlungcancer
AT ishiikentaro minimizingdosevariationfromtheinterplayeffectinstereotacticradiationtherapyusingvolumetricmodulatedarctherapyforlungcancer
AT okadawataru minimizingdosevariationfromtheinterplayeffectinstereotacticradiationtherapyusingvolumetricmodulatedarctherapyforlungcancer
AT nakahararyuta minimizingdosevariationfromtheinterplayeffectinstereotacticradiationtherapyusingvolumetricmodulatedarctherapyforlungcancer
AT kishimotoshun minimizingdosevariationfromtheinterplayeffectinstereotacticradiationtherapyusingvolumetricmodulatedarctherapyforlungcancer
AT kawamoritaryu minimizingdosevariationfromtheinterplayeffectinstereotacticradiationtherapyusingvolumetricmodulatedarctherapyforlungcancer
AT nishimurayasumasa minimizingdosevariationfromtheinterplayeffectinstereotacticradiationtherapyusingvolumetricmodulatedarctherapyforlungcancer